文献速递头颈神经MR

头颈部癌症治疗后改变与复发的鉴别:动态对比增强灌注MRI归一化参数与DWI-ADC

Normalized Parameters of Dynamic Contrast-Enhanced Perfusion MRI and DWI-ADC for Differentiation between Posttreatment Changes and Recurrence in Head and Neck Cancer.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-07-14

本研究纳入51例头颈部癌症随访患者(25例复发、26例良性治疗后改变),分析动态对比增强MRI归一化参数与归一化DWI-ADC。复发组归一化血浆容积、K trans、曲线下面积及wash-in显著高于良性改变组,归一化平均ADC显著低于良性改变组;联合参数AUC为0.97(95% CI,0.93-1)。

要点

  • 复发组归一化血浆容积、K trans、曲线下面积及wash-in显著高于良性治疗后改变组。
  • 复发组归一化平均ADC显著低于良性治疗后改变组。
  • 联合显著归一化DCE-MRI参数与归一化平均ADC的AUC为0.97(95% CI,0.93-1)。

核心结论

  • 归一化动态对比增强MRI参数、归一化平均ADC及其联合应用能有效鉴别头颈部癌症的复发与良性治疗后改变。

研究设计与样本

  • 纳入51例有头颈部癌症病史并接受随访动态对比增强MRI及DWI-ADC的患者,其中25例复发、26例良性治疗后改变;分析ROI与参考区域的定量及半定量DCE-MRI参数和ADC,并以ROI除以参考区域计算归一化参数。

诊断标准与关键数值

  • 复发组归一化血浆容积、归一化K trans、归一化曲线下面积及归一化wash-in显著高于良性治疗后改变组(P=.003至<.001);复发组归一化平均ADC显著低于良性治疗后改变组(P<.001);显著归一化DCE-MRI参数(归一化血浆容积、归一化单位组织体积细胞外血管外间隙容积、归一化K trans、归一化曲线下面积及归一化wash-in)联合归一化平均ADC的AUC为0.97(95% CI,0.93-1)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Differentiating recurrence from benign posttreatment changes has clinical importance in the imaging follow-up of head and neck cancer. This study aimed to investigate the utility of normalized dynamic contrast-enhanced MR imaging and ADC for their differentiation.

MATERIALS AND METHODS: This study included 51 patients with a history of head and neck cancer who underwent follow-up dynamic contrast-enhanced MR imaging with DWI-ADC, of whom 25 had recurrences and 26 had benign posttreatment changes. Quantitative and semiquantitative dynamic contrast-enhanced MR imaging parameters and ADC of the ROI and reference region were analyzed. Normalized dynamic contrast-enhanced MR imaging parameters and normalized DWI-ADC parameters were calculated by dividing the ROI by the reference region.

RESULTS: Normalized plasma volume, volume transfer constant between extravascular extracellular space and blood plasma per minute (K trans), area under the curve, and wash-in were significantly higher in patients with recurrence than in those with benign posttreatment change (P = .003 to <.001). The normalized mean ADC was significantly lower in patients with recurrence than in those with benign posttreatment change (P < .001). The area under the receiver operating characteristic curve of the combination of normalized dynamic contrast-enhanced MR imaging parameters with significance (normalized plasma volume, normalized extravascular extracellular space volume per unit tissue volume, normalized K trans, normalized area under the curve, and normalized wash-in) and normalized mean ADC was 0.97 (95% CI, 0.93-1).

CONCLUSIONS: Normalized dynamic contrast-enhanced MR imaging parameters, normalized mean ADC, and their combination were effective in differentiating recurrence and benign posttreatment changes in head and neck cancer.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Baba, Kurokawa, Rawie, et al. Normalized Parameters of Dynamic Contrast-Enhanced Perfusion MRI and DWI-ADC for Differentiation between Posttreatment Changes and Recurrence in Head and Neck Cancer. AJNR Am J Neuroradiol. 2022. PMID: 35835592. doi:10.3174/ajnr.A7567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。